Qube Research & Technologies Ltd

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 1729829 LONDON, X0

Position in LCTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$410,106

+$57,155 QoQ

Shares Held

259,561

+22.8% QoQ

Ownership

0.104%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Qube Research & Technologies Ltd holds $2,030,593,180 across 187 Biotechnology names. LCTX ranks #142 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	838,187	$277,330,932
2	FOLD	AMICUS THERAPEUTICS, INC.	8,809,340	$127,383,056
3	ROIV	Roivant Sciences Ltd.	3,450,904	$95,590,040
4	RPRX	Royalty Pharma plc	1,524,511	$73,130,792
5	REGN	Regeneron Pharmaceuticals, Inc.	83,358	$64,405,725
6	AXSM	Axsome Therapeutics, Inc.	335,334	$56,678,152
7	RVMD	Revolution Medicines, Inc.	553,290	$53,807,452
8	CYTK	Cytokinetics Inc	779,446	$51,373,285

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$410,106	259,561	+22.8%	Shares	Sole	2026-05-15
2025-12-31	$352,951	211,348	+441.4%	Shares	Sole	2026-02-17
2025-06-30	$35,522	39,036	-42.8%	Shares	Sole	2025-08-14
2024-06-30	$68,286	68,286	+420.4%	Shares	Sole	2024-08-14
2024-03-31	$19,422	13,123	-94.1%	Shares	Sole	2024-05-14
2023-03-31	$332,919	221,946	+61.3%	Shares	Sole	2023-05-15
2022-12-31	$160,954	137,568	+33.1%	Shares	Sole	2023-02-14
2022-09-30	$116,753	103,322	+14.9%	Shares	Sole	2022-11-14
2022-06-30	$142,136	89,960	-53.0%	Shares	Sole	2022-08-15
2021-03-31	$449,985	191,483	+1.9%	Shares	Sole	2021-05-14
2020-12-31	$330,816	187,964	+94.4%	Shares	Sole	2021-02-16
2020-09-30	$90,901	96,704	-28.4%	Shares	Sole	2020-11-12
2020-06-30	$117,570	135,138	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.